Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer

Prostate cancer (PCa) is the most common noncutaneous cancer diagnosis and the second leading cause of cancer-related deaths among men in the United States. Effective treatment modalities for advanced metastatic PCa are limited. Immunotherapeutic strategies based on T cells and antibodies represent...

Full description

Bibliographic Details
Main Authors: Marc Schmitz, Manfred P. Wirth, Michael Bachmann, Susanne Füssel, Andrea Kiessling, Rebekka Wehner
Format: Article
Language:English
Published: MDPI AG 2012-02-01
Series:Cancers
Subjects:
antibodies
dendritic cells
immunotherapy
prostate cancer
T cells
Online Access:http://www.mdpi.com/2072-6694/4/1/193/

Similar Items

Similar Items